Lipitor News - very latest news developments cholesterol medication - Lipitor

Thursday, July 03, 2008

The Statin Showdown

The very latest news and developments about the cholesterol medication - Lipitor

When the blockbuster cholesterol pill Vytorin failed to best the less potent generic in a clinical trial earlier this year, many cardiologists were shocked.


Printable Version

Wednesday, July 02, 2008

U.S. study shows 150 percent jump in statin use

Use of cholesterol-lowering drugs called statins rose by 156 percent between 2000 and 2005, with spending jumping from $7.7 billion to $19.7 billion, the U.S. Agency for Healthcare Research and Quality reported ...


Printable Version

Tuesday, July 01, 2008

Ask The Doctor: Coughing For Heart Attack; Lipitor

Avis from Philadelphia called NBC 10 to ask, "Can you stop a heart attack by coughing?" She said she sometimes gets e-mails saying you can and wonders if it's true.


Printable Version

Saturday, June 28, 2008

Analyst Says Bristol-Myers A Buyout Target

The pharma industry, like many other industries in the down U.S. economy, is due to consolidate.


Printable Version

Thursday, June 26, 2008

Examine the Lipitor Market Analysis and Forecasts Report, 2007-2012, 2017 and 2023

In 2006, Pfizer's Lipitor generated global revenues of $13.6bn, making it the best selling drug in pharmaceutical history.


Printable Version

Tuesday, June 24, 2008

Editorial: Risky de-risking

Has Malvinder Singh truly freed Ranbaxy from risk by opting for an out-of-court settlement with Pfizer over Lipitor as he has claimed? The markets and analysts certainly thought otherwise.


Printable Version

Sunday, June 22, 2008

Another option for high cholesterol

I'm sure you've heard of 'statins' like Lipitor , Zocor , and Pravachol . These powerful cholesterol-lowering medicines are widely used some people make jokes about adding them to the water supply.


Printable Version

Friday, June 20, 2008

Ranbaxy stock clobbered

Mumbai, June 19 : Shares of Ranbaxy Laboratories Ltd slid on the stock markets today on speculation that the settlement with Pfizer Inc over cholesterol-lowering drug Lipitor would benefit Ranbaxy only ...


Printable Version

Lipitor won't go generic until 2011

Published Thursday, June 19, 2008 at 4:30 a.m. Last updated Thursday, June 19, 2008 at 2:40 a.m. For people with high cholesterol, the wait for a cheaper version of Lipitor has gotten longer.


Printable Version

Wednesday, June 18, 2008

Pfizer settles U.S. Lipitor patent dispute with Ranbaxy

Under terms of the settlement, Ranbaxy will obtain a license effective Nov. 30, 2011, to sell generic versions of Pfizer's cholesterol-lowering drug Lipitor and high blood-pressure and cholesterol treatment ...


Printable Version

Research Shows Why Statins Don't Work for Everyone

A genetic quirk in the production of one protein helps explain why some people don't get the full cholesterol-lowering benefit of statin drugs, researchers report.


Printable Version

Sunday, June 15, 2008

Lipitor online | Buy lipitor online | Lipitor cost

People may think that if they buy lipitor online, they may have to pay high lipitor cost and often become puzzled while deciding from where to buy lipitor.


Printable Version

Friday, June 13, 2008

Pharmaceutical Companies to Lay Off Workers

GlaxoSmithKline and Merck are about to lay off workers. But it's not just falling sales, it's increased competition.


Printable Version

Wednesday, June 11, 2008

Dueling Fools: Pfizer Bull

A year ago, I would have never penned this article. Six months ago, when my nemesis for this duel picked Pfizer as the worst stock for 2006 , I cheered him on by giving the article a recommendation.


Printable Version

Monday, June 09, 2008

Chinese Supplement May Cut Heart Risk

When 61-year-old Mark Aloe learned that he had high cholesterol and a family history of heart disease nearly 20 years ago, he immediately set out on the standard course of treatment for heart patients with high ...


Printable Version

Top Headlines
1.The Statin Showdown
2.U.S. study shows 150 percent jump in statin use
3.Ask The Doctor: Coughing For Heart Attack; Lipitor
4.Analyst Says Bristol-Myers A Buyout Target
5.Examine the Lipitor Market Analysis and Forecasts Report, 2007-2012, 2017 and 2023
6.Editorial: Risky de-risking
7.Another option for high cholesterol
8.Ranbaxy stock clobbered
9.Lipitor won't go generic until 2011
10.Pfizer settles U.S. Lipitor patent dispute with Ranbaxy